Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;36(6):391-8.
doi: 10.4093/dmj.2012.36.6.391. Epub 2012 Dec 12.

Molecular mechanisms of appetite regulation

Affiliations

Molecular mechanisms of appetite regulation

Ji Hee Yu et al. Diabetes Metab J. 2012 Dec.

Abstract

The prevalence of obesity has been rapidly increasing worldwide over the last several decades and has become a major health problem in developed countries. The brain, especially the hypothalamus, plays a key role in the control of food intake by sensing metabolic signals from peripheral organs and modulating feeding behaviors. To accomplish these important roles, the hypothalamus communicates with other brain areas such as the brainstem and reward-related limbic pathways. The adipocyte-derived hormone leptin and pancreatic β-cell-derived insulin inform adiposity to the hypothalamus. Gut hormones such as cholecystokinin, peptide YY, pancreatic polypeptide, glucagon-like peptide 1, and oxyntomodulin transfer satiety signals to the brain and ghrelin relays hunger signals. The endocannabinoid system and nutrients are also involved in the physiological regulation of food intake. In this article, we briefly review physiological mechanisms of appetite regulation.

Keywords: Adiposity; Appetite; Hypothalamus; Leptin; Satiety.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1
Hypothalamic nuclei involved in appetite regulation. ARC, arcuate nucleus; AM, amygdala; CC, corpus callosum; CCX, cerebral cortex; DMN, dorsomedial nucleus; FX, fornix; HI, hippocampus; LHA, lateral hypothalamic area; ME, median eminence; OC, optic chiasm; PFA, perifornical area; PVN, paraventricular nucleus; SE, septum; 3V, third ventricle; TH, thalamus; VMN, ventromedial nucleus.
Fig. 2
Fig. 2
A schematic representation of the multiple systems regulating appetite. AgRP, agouti-related peptide; ARC, arcuate nucleus; CCK, cholecystokinin; GLP-1, glucagon-like peptide 1; LHA, lateral hypothalamic area; NPY, neuropeptide Y; NTS, nucleus of the solitary tract; OXM, oxyntomodulin; POMC, pro-opiomelanocortin; PP, pancreatic polypeptide; PVN, paraventricular nucleus; PYY, peptide YY.

Similar articles

  • Obesity and appetite control.
    Suzuki K, Jayasena CN, Bloom SR. Suzuki K, et al. Exp Diabetes Res. 2012;2012:824305. doi: 10.1155/2012/824305. Epub 2012 Aug 1. Exp Diabetes Res. 2012. PMID: 22899902 Free PMC article. Review.
  • Neuroendocrine control of food intake.
    Valassi E, Scacchi M, Cavagnini F. Valassi E, et al. Nutr Metab Cardiovasc Dis. 2008 Feb;18(2):158-68. doi: 10.1016/j.numecd.2007.06.004. Epub 2007 Dec 3. Nutr Metab Cardiovasc Dis. 2008. PMID: 18061414 Review.
  • How palatable food disrupts appetite regulation.
    Erlanson-Albertsson C. Erlanson-Albertsson C. Basic Clin Pharmacol Toxicol. 2005 Aug;97(2):61-73. doi: 10.1111/j.1742-7843.2005.pto_179.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 15998351 Review.
  • Appetite regulation: an overview.
    Dhillo WS. Dhillo WS. Thyroid. 2007 May;17(5):433-45. doi: 10.1089/thy.2007.0018. Thyroid. 2007. PMID: 17542673 Review.
  • Gut hormones and the control of appetite.
    Small CJ, Bloom SR. Small CJ, et al. Trends Endocrinol Metab. 2004 Aug;15(6):259-63. doi: 10.1016/j.tem.2004.06.002. Trends Endocrinol Metab. 2004. PMID: 15358278 Review.

Cited by

References

    1. World Health Organization (WHO) Obesity. Geneva: WHO; 2008.
    1. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523–1529. - PubMed
    1. Heisler LK, Cowley MA, Tecott LH, Fan W, Low MJ, Smart JL, Rubinstein M, Tatro JB, Marcus JN, Holstege H, Lee CE, Cone RD, Elmquist JK. Activation of central melanocortin pathways by fenfluramine. Science. 2002;297:609–611. - PubMed
    1. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997;88:131–141. - PubMed
    1. Tao YX. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Mol Cell Endocrinol. 2005;239:1–14. - PubMed